A Physiologically‐Based Pharmacokinetic Model for Targeting Calcitriol‐Conjugated Quantum Dots to Inflammatory Breast Cancer Cells

Clinical and Translational Science- United Kingdom

doi 10.1111/cts.12664

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

July 15, 2019

Authors

Rachel J. Schaefer

Kenneth L. Golen

Prasad Dhurjati

Publisher

Wiley

Related search

A Physiologically-Based Pharmacokinetic Model for Vancomycin

SIAM Undergraduate Research Online

English

Physiologically Based Pharmacokinetic (PBPK) Model of Ivermectin (IVM)

English

Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells

Artificial Cells, Nanomedicine and Biotechnology

Biomedical Engineering

Pharmaceutical Science

English

Quantum Dots Based Probes Conjugated to Annexin v for Photostable Apoptosis Detection and Imaging

English

Graphene Quantum Dot-Based Theranostic Agents for Active Targeting of Breast Cancer

Chemical Engineering

English

The Implications of Using a Physiologically Based Pharmacokinetic (PBPK) Model for Pesticide Risk Assessment

Environmental Health Perspectives

Occupational Health

English

Physiologically Based Pharmacokinetic Model of Lapatinib Developed in Mice and Scaled to Humans

Journal of Pharmacokinetics and Pharmacodynamics

English

Accumulation and Distribution of Non-Targeted and Anti-Cd44-Conjugated Quantum Dots in Distinct Phenotypes of Breast Cancer

Journal of Nanomedicine & Nanotechnology

English

Chemotaxis Model for Breast Cancer Cells Based on Signal-To-Noise Ratio

Biophysical Journal

English